Header
Header
Article

New patent expiration for Allergan drug VIIBRYD – DrugPatentWatch


Copyright © DrugPatentWatch. Originally published at New patent expiration for Allergan drug VIIBRYD


Annual Drug Patent Expirations for VIIBRYD

Viibryd is a drug marketed by Allergan and is included in one NDA. It is available from four suppliers. There are four patents protecting this drug and one Paragraph IV challenge.

VIIBRYD drug price trends.

Drug patent litigation for VIIBRYD.

The generic ingredient in VIIBRYD is vilazodone hydrochloride. Four suppliers are listed for this compound. Additional details are available on the vilazodone hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent expiration for Allergan drug VIIBRYD



Source link

Back to top button